Study finds single-use bronchoscopes reduce hospital readmission rates by half

The Ambu aScope4 single-use bronchoscope [Photo courtesy of Ambu]

A study of 14,228 bronchoscopy procedures found sterile, disposable scopes reduced readmission rates by more than half.

The study, authored by Ambu consultant Dr. Hudson Garrett, analyzed procedures at inpatient hospitals as well as outpatient ambulatory facilities.

He found that 3.6 percent of patients treated with a single-use, flexible bronchoscope were readmitted within 30 days, compared to 7.7 percent of patients whose procedures used reusable scopes.

“The data analysis demonstrates significant clinical benefits of single-use bronchoscopes in reducing readmission rates and patient risk,” Garrett said in an Ambu news release. “To reduce these risks, the use of sterile single-use bronchoscopes should be considered to eliminate reprocessing failures, improve overall operational efficiency and reduce potential acquisition of healt…

Read more
  • 0

Medtronic hires social-media-minded chief medical officer for its gastrointestinal unit

Dr. Austin Chiang is chief medical officer of Medtronic’s Gastrointestinal business [Photo courtesy of Medtronic]

Medtronic (NYSE:MDT) today said it has hired Dr. Austin Chiang as the first chief medical officer of the medical device maker’s gastrointestinal business.

Chiang is an assistant professor of medicine at Sidney Kimmel Medical College and director of the Endoscopic Bariatric Program at Thomas Jefferson University Hospital, both in Philadelphia. He holds a master’s degree in public health from the Harvard T.H. Chan School of Public Health.

“I am thrilled to be joining Medtronic at such an innovative time in healthcare and especially in the gastrointestinal space, helping to deliver on what is a promising future for those in need of innovative GI care around the world,” Chiang said in a news release. “I look forward to joining a world-renowned team of brilliant engin…

Read more
  • 0

Boston Scientific settles patent dispute with Micro-Tech Endoscopy over hemostasis clips

Micro-Tech’s SureClip

Boston Scientific (NYSE:BSX) said yesterday that it has resolved its patent infringement litigation against Micro-Tech Endoscopy over hemostasis clips used in endoscopy procedures.

Boston Scientific said it will grant a five-year, royalty-bearing license to Ann-Arbor, Mich.-based Micro-Tech for the patented hemostasis clip technology. The clips are applied to tissue or blood vessels to stop gastrointestinal bleeding.

In exchange, Micro-Tech agreed to drop its patent validity challenges, Marlborough, Massachusetts-based Boston Scientific said.

“The settlement resolves all worldwide litigation between the companies,” Boston Scientific said in a news release.

Boston Scientific sued not only Micro-Tech, but also Chinese manufacturer Micro-Tech Nanjing and distributor Henry Schein. Boston Scientific’s lawsuit — filed in U.S. District Court in Delaware — claimed th…

Read more
  • 0

How vapor degreasing is helping to future-proof medical device reliability

The demand for digital wellness means an increasing need for small, complex electronic components. [Image courtesy of MicroCare]

Precision cleaning of electronic medical devices boosts reliability.

Jay Tourigny, MicroCare

COVID-19 has brought the importance of wearable and remote monitoring and diagnostic devices to the forefront. But these devices, with their intricate PCBAs (printed circuit board assemblies) must deliver reliable and consistent performance, particularly as they are often used in devices that are life-sustaining.

Cleaning is a key contributor to PCBA performance consistency and should be factored in when designing complex and multifaceted electronics. What cleaning processes should be adopted and how do you ensure cleanliness standards are met?

Why is reliability important?

The medical electronics market is estimated to be worth $6.3 billion in 2021 and projected to reach $8.…

Read more
  • 0

Freudenberg Medical launches SpeakFree HME valve for laryngectomy care

The SpeakFree HME hands free valve [Photo courtesy of Freudenberg Medical]

Freudenberg Medical today announced the commercial launch of its Blom-Singer SpeakFree heat and moisture exchange (HME) hands free valve.

The device is designed for people who have undergone a total laryngectomy, or the removal of a person’s larynx or voice box, resulting in loss of speech.

Carpinteria, California-based Freudenberg Medical’s InHealth Technologies unit said its SpeakFree HME is the first single-use HME cartridge with an adjustable valve that does not require manual closure to speak, enabling hands-free speech for individuals with a tracheoesophageal puncture and voice prosthesis. The daily disposable product is adjustable for an individual’s activity and offers flexibility of hands-free and digital occlusion.

“This product is a game-changer and demonstrates InHealth’s commitment to ongoing innova…

Read more
  • 0

Luminopia’s new FDA-approved therapy uses TV to treat lazy eye in kids

Luminopia announced today that it received FDA de novo approval for its prescription therapy for improving vision in children with lazy eye.

Cambridge, Massachusetts-based Luminopia’s prescription Luminopia One holds indication for improvement in visual acuity in children between ages four and seven with lazy eye (amblyopia) associated with anisometropia and/or mild strabismus, having received treatment instructions as prescribed by a trained eye-care professional, according to a news release.

“The FDA approval of a new digital therapy with robust clinical evidence for children affected by amblyopia is a major development. Amblyopia is one of the most common conditions I manage as a clinician, and patients, parents and physicians often struggle with current therapies,” Boston Children’s Hospital Ophthalmologist-in-Chief & Richard Robb Chair in Opthalmology & advisor to Luminopia Dr. David G. Hunte said in the release. “The idea of prescribin…

Read more
  • 0

Tessy Plastics has a deal for a new campus in New York

Tessy Plastics today said it has a deal to buy a three-building campus totaling about 1.5 million square feet in Webster, New York.

The three buildings — 200, 210 and 214 at 800 Phillips Road, formerly owned by Xerox — are about an hour’s drive from Skaneateles, New York-based Tessy’s other facilities in Upstate New York.

The largest of the three buildings measures more than 750,000 square feet.

The purchase is expected to close by the end of 2021, and the three buildings will be subdivided by that time. Two of the three buildings are vacant, with the third to be unoccupied by 2022.

Tessy plans to lease some of the space to third-party tenants and use the rest as warehouse space. All three buildings are likely to eventually become production plants.

“Knowing that we have the extra space to expand in the future is a strategic initiative that has always been important to Tessy,” President Roland Beck said in a news release. “We’ve had g…

Read more
  • 0

Diversity in medtech: Just 21% of executive roles are held by women

The prevalence of women in corporate leadership positions within the medical device industry remains low, and the rate of increase is stagnant despite new initiatives to increase diversity in the industry.

Just 21% of top executives at the world’s 100 world’s biggest medical device companies are women, according to an analysis of Medical Design & Outsourcing‘s annual Big 100 breakdown of the top revenue-generating medical device companies in the world.

The analysis involved seeing who shows up on the leadership pages on the corporations’ websites. While the overall number of women executives on such pages is up 1 percentage point from 2020, the average percentage of women in medtech companies’ top executive ranks remained unchanged from last year at 19%.

“The medtech workforce must mirror the patients we serve if we are going to succeed in delivering innovative technology to populations who need it,” AdvaMed chief financial officer and ch…

Read more
  • 0

Intuitive Surgical highlights supply chain risk, addresses Medtronic’s Hugo launch

Intuitive Surgical CFO Marshall Mohr [Photo courtesy of Intuitive Surgical]

Intuitive Surgical executives today said delays and price increases are working their way through the medtech supply chain, likely resulting in higher production costs in the months ahead and the potential for delayed development and regulatory activity.

“I don’t think I can say it’s getting better. it’s a difficult situation and will continue for some time. … I’m not sure I want to say the inflation word, that it has hit us and is here to stay, but we are seeing some suppliers raise costs,” CFO Marshall Mohr said on a conference call to discuss the surgical robotics maker’s performance in the third quarter.

“It’s a problem we highlight just to make sure that you’re aware of the risk,” Mohr said.

Mohr and CEO Gary Guthart said Intuitive has so far been able to resolve regularly occurring suppl…

Read more
  • 0

Intuitive Surgical names new C-suite leaders, reports Street-beating Q3

Intuitive Surgical CEO Gary Guthart [Photo courtesy of Intuitive]

Intuitive Surgical (NSDQ:ISRG) today announced changes in the ranks of its senior leadership as the surgical robotics maker released Q3 results that exceeded expectations.

Sunnyvale, California-based Intuitive launched two new functional organizations — Strategy and Growth, and Global Business Services — and named leaders who will take over effective Jan. 1.

Dave Rosa, a 25-year veteran at Intuitive, will fill the new position of EVP and chief strategy and growth officer, while Henry Charlton (with more than 18 years of experience at the company) will serve as chief commercial officer.

Marshall Mohr, who has served as CFO for 15 years, will take the new position of EVP for Global Business Services. Replacing Mohr at CFO is Jamie Samath, who has been with Intuitive since 2013 and oversaw most finance functions as SVP of finance.

Read more
  • 0

Johnson & Johnson discloses two-year delay for Ottava robot

Johnson & Johnson (NYSE:JNJ) today confirmed that it experienced a “temporary setback” with its Ottava surgical robotic system.

Speaking on the company’s third-quarter earnings call, transcribed by SeekingAlpha, J&J EVP Joseph Wolk said that while the company maintains its commitment to developing a general surgery offering with Ottava, the platform’s development timeline has been pushed back about two years due to multiple factors.

Get the full story at our sister site, MassDevice.

Read more
  • 0

BICO’s Cytena launches C.Station automated cell line development platform for antibody and gene therapies

Cytena’s C.Station platform [Photo courtesy of Cytena]

BICO Group subsidiary Cytena today announced the launch of its C.Station platform for automating the development of stable cell lines.

Cytena said in a news release that C.Station is a user-friendly platform that covers the entire cell line development workflow, from single-cell cloning of transfected cells to the selection of high-producing clones and upscaling.

Cytena CEO Dr. Julian Riba called it “a key step in advancing the Bio Convergence revolution by combining several proven technologies, cell cultures, and smart software to produce monoclonal antibodies and viral vectors for gene therapy.”

Cytena patented its single-cell dispensing technology in 2014 as a spin-off from the University of Freiburg in Germany. Like BICO’s name (an abbreviation of “bio convergence”), Cytena’s name is a combination of the Latin…

Read more
  • 0